Clinicopathological significance and potential drug target of RUNX3 in breast cancer

BACKGROUND: Previous reports indicate that RUNX3 is a tumor suppressor in several types of human tumors, including breast cancer (BC). However, the correlation between RUNX3 hypermethylation and the incidence of BC remains unclear. In this study, we conducted a systematic review and meta-analysis ai...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Ying-Ying, Chen, Chao, Kong, Fan-fei, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266273/
https://www.ncbi.nlm.nih.gov/pubmed/25525332
http://dx.doi.org/10.2147/DDDT.S71815

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4266273/
https://www.ncbi.nlm.nih.gov/pubmed/25525332
http://dx.doi.org/10.2147/DDDT.S71815

Ejemplares similares